Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
Abstract International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate fo...
Main Authors: | Tamiru S. Degaga, Sophie Weston, Tedla T. Tego, Dagimawie T. Abate, Ashenafi Aseffa, Adugna Wayessa, Ric N. Price, Asrat Hailu, Kamala Thriemer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12936-020-03279-5 |
Similar Items
-
Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
by: Degaga, TS, et al.
Published: (2020) -
“Becoming myself”: how participants in a longitudinal substance use disorder recovery study experienced receiving continuous feedback on their results
by: Thomas Solgaard Svendsen, et al.
Published: (2020-01-01) -
Providing trial results to participants in phase III pragmatic effectiveness RCTs: a scoping review
by: Hanne Bruhn, et al.
Published: (2021-05-01) -
Assessing research participant preferences for receiving study results
by: Sarah Cook, et al.
Published: (2020-06-01) -
Tracking Users for a Targeted Dissemination
by: Philippe Bautier, et al.
Published: (2015-12-01)